Evidence map›Paper›PMID 41210248›Full record

ReviewFrontiers in cell and developmental biology2025

Considerations and implications of current

Ana N Strat, Preethi S Ganapathy

Abstract readReview
In one paragraph

Review in Frontiers in cell and developmental biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Generation of xenobiotic free retinofugal assembloids.Frontiers in cell and developmental biology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ana N StratDepartment of Ophthalmology and Visual Sciences, SUNY Upstate Medical University, Syracuse, NY, United States.
Preethi S GanapathyDepartment of Ophthalmology and Visual Sciences, SUNY Upstate Medical University, Syracuse, NY, United States.

Funding

Investigating mechanosensation in the glaucomatous optic nerve headK08EY031755 · NEI · UPSTATE MEDICAL UNIVERSITY · PI GANAPATHY, PREETHI · 2021 to 2025
$1.1M
Optic nerve head astrocyte sensitivity to glaucomatous insultR01EY036880 · NEI · UPSTATE MEDICAL UNIVERSITY · PI Preethi Ganapathy · 2025 to 2026
$777k
Optic nerve head cellular interactions in response to mechanical strain and fibrosisR21EY036198 · NEI · UPSTATE MEDICAL UNIVERSITY · PI GANAPATHY, PREETHI, MCDOWELL, COLLEEN MARY · 2024 to 2025
$447k
NEI NIH HHS K08 EY031755NEI NIH HHS R01 EY036880NEI NIH HHS R21 EY036198
6 · The paper itself

Abstract

The optic nerve head (ONH) is a primary site of biomechanical strain within the eye. Here, tensile, compressive and shear forces can impact both physiologic function and pathologic dysfunction of the tissue. Under healthy conditions, the ONH can withstand dynamic fluctuations in intraocular pressure (IOP), which is the main driver of biomechanical strain. In glaucoma, pathologic biomechanical strains lead to disrupted cellular homeostasis, increased ECM remodeling and fibrosis, loss of retinal ganglion cells (RGCs), and irreversible blindness.

Indexed as

astrocytesbioengineeringcompressionglaucomahydrogelslamina cribrosa cellsstretchtension

Identifiers

PMID41210248
PMCPMC12592179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.